Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$4.99M Buy
18,384
+15,546
+548% +$4.11M 0.2% 81
2017
Q1
$776K Sell
2,838
-1,598
-36% -$452K 0.04% 139
2016
Q4
$1.26M Buy
+4,436
New +$1.31M 0.08% 85

Other funds holding BIIB

CaixaBank, S.A.'s BIIB Position: Q2 2017 in Review

CaixaBank, S.A. increased its Biogen (BIIB) stake by 548% in Q2 2017, buying an estimated $4.11M and bringing the position to 18,384 shares worth $4.99M. The position accounts for 0.2% of the portfolio, ranked #81.

CaixaBank, S.A. first reported a position in BIIB in Q4 2016 and has held it in 3 quarters since. 993 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

  • CaixaBank, S.A. held 18,384 shares of Biogen worth $4.99M as of Q2 2017.
  • CaixaBank, S.A. bought 15,546 Biogen shares in Q2 2017, an estimated $4.11M.
  • Biogen made up 0.2% of CaixaBank, S.A.'s portfolio in Q2 2017, its #81 holding.
  • CaixaBank, S.A. first reported a position in Biogen in Q4 2016 and has held it in 3 quarters since.
  • 993 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on CaixaBank, S.A.'s 13F filing for Q2 2017.